Create

Sign in to ReadmeX

or

How we handle your data: Privacy Policy

ReadmeX

Your AI reading companion

What would you like to catch up on?

Pick a briefing, or ask your own question.

Your community and people briefings stay personal to you.

Story

Chinese Medical Companies Diversify Into AI and Semiconductor Funds

AI summary

TMTPost, publishing commentary from 医药研究社, reports that several Chinese listed medical and health companies are allocating capital to AI and semiconductor funds. Yifan Pharmaceutical and Tebao Biological each committed 100 million yuan to funds, although Yifan's announcement only specified emerging industries, while Yuwell Medical subscribed to a fund focused on AI, semiconductor chips and integrated circuits. BY-HEALTH separately invested 50 million yuan in Yuanli Semiconductor, illustrating a direct minority-stake route alongside fund investments.

In-depth insight

The disclosures show a widening asset-allocation trend among Chinese medical companies, but the cited transactions remain selective financial investments rather than evidence of completed strategic transformations into AI or semiconductors.

(本文作者为 医药研究社,钛媒体经授权发布)

文  | 医药研究社

近期,多家医药上市公司发布参设、参投或认购基金进展公告。从资金投向来看,部分医药及大健康类上市公司从“投药”部分转向“投芯片、投AI”。

亿帆医药全资子公司合肥欣竹生物科技有限公司出资1亿元做有限合伙人,参与设立天津高榕长赢股权投资基金合伙企业(有限合伙),公告对投向的表述是“主要投向新兴产业领域”;特宝生物以1亿元认购天津砺思星深股权投资合伙企业(有限合伙)份额,该基金聚焦人工智能,这笔投资同样因与关联人共同投资构成关联交易。时间再往前一点,保健食品企业汤臣倍健以5000万元投资原粒(北京)半导体技术有限公司,持股0.97%,公司定性为财务性投资,标的仍在亏损,因董事长梁允超配偶间接持股,构成关联交易。

说“药企不投药”当然夸张,但钱在分流是真的。比“投了什么”更值得看的,是这钱为什么此时、以此种方式挪过去。

#Yifan Pharmaceutical#Tebao Biological#Yuwell Medical#BY-HEALTH#Yuanli Semiconductor#Baipu Sai Si

Original · 7 min readRead the original
Group chat

No comments yet. Start the conversation.